ReviewThe pharmacogenomics journal2016

Genetic markers predicting sulphonylurea treatment outcomes in type 2 diabetes patients: current evidence and challenges for clinical implementation.

N K Loganadan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.